CL:0000076

Name:	squamous epithelial cell
Namespace:	FANTOM

Ontology association <br>Each term has an is_a parent in the Cell ontology, which has a linkage to an another entity and FANTOM5 samples.Libraries were grouped into mutually exclusive facets according to the FANTOM5 sample ontology mapping to Cell ontologies.<br><br>link to ontology dataset<br>data

---

Parents

is_a:	CL:0000066(epithelial cell)

Children

is a:	CL:0000071 (blood vessel endothelial cell),CL:0000077 (mesothelial cell),CL:0000240 (stratified squamous epithelial cell),CL:0000575 (corneal epithelial cell)
derives from:	FF:0102024 (squamous cell carcinoma cell line sample)

Ontology Tree: Loaded from BioPortal

Ontorolgy tree(Small window open)

FF samples<br>It includes FANTOM5 samples that overlay the Cell ontology.

---

Human (Homo sapiens)

• 10412-106B7 (malignant trichilemmal cyst cell line:DJM-1)
• 10426-106D3 (epidermoid carcinoma cell line:A431)
• 10431-106D8 (epidermoid carcinoma cell line:Ca Ski)
• 10434-106E2 (oral squamous cell carcinoma cell line:Ca9-22)
• 10457-106G7 (squamous cell lung carcinoma cell line:LC-1F)
• 10463-106H4 (squamous cell carcinoma cell line:EC-GI-10)
• 10486-107A9 (squamous cell lung carcinoma cell line:EBC-1)
• 10493-107B7 (mesothelioma cell line:ACC-MESO-1)
• 10494-107B8 (mesothelioma cell line:ACC-MESO-4)
• 10501-107C6 (squamous cell lung carcinoma cell line:RERF-LC-AI)

... further results Mouse (Mus musculus)

• 10412-106B7 (malignant trichilemmal cyst cell line:DJM-1)
• 10426-106D3 (epidermoid carcinoma cell line:A431)
• 10431-106D8 (epidermoid carcinoma cell line:Ca Ski)
• 10434-106E2 (oral squamous cell carcinoma cell line:Ca9-22)
• 10457-106G7 (squamous cell lung carcinoma cell line:LC-1F)
• 10463-106H4 (squamous cell carcinoma cell line:EC-GI-10)
• 10486-107A9 (squamous cell lung carcinoma cell line:EBC-1)
• 10493-107B7 (mesothelioma cell line:ACC-MESO-1)
• 10494-107B8 (mesothelioma cell line:ACC-MESO-4)
• 10501-107C6 (squamous cell lung carcinoma cell line:RERF-LC-AI)

... further results

Enrichment analysis: top 100 FFCP enriched with this ontology termTOP 100 FANTOM5 Cage Peaks enriched with CL:0000076 (squamous epithelial cell), sorted by p-values <br>Analyst: Hideya Kawaji<br><br>link to source dataset <br>human : data <br>mouse : data

---

Copy Excel CSV PDF

Search:

P-value	FFCP	Short description

P-value	FFCP	Short description
4.01e-41	FFCP PHASE2:Hg19::chr18:33046982..33046991,-	p@chr18:33046982..33046991, -
4.01e-41	FFCP PHASE1:Hg19::chr18:33046982..33046991,-	p@chr18:33046982..33046991, -
7.09e-34	FFCP PHASE1:Hg19::chr7:139741849..139741879,-	p12@PARP12
7.09e-34	FFCP PHASE2:Hg19::chr7:139741849..139741879,-	p12@PARP12
9.9e-34	FFCP PHASE1:Hg19::chr2:56216687..56216727,-	p1@MIR216A
9.9e-34	FFCP PHASE2:Hg19::chr2:56216687..56216727,-	p1@MIR216A
6.61e-33	FFCP PHASE1:Hg19::chr6:78171774..78171792,+	p@chr6:78171774..78171792, +
6.61e-33	FFCP PHASE2:Hg19::chr6:78171774..78171792,+	p@chr6:78171774..78171792, +
1.58e-32	FFCP PHASE2:Hg19::chr18:33047157..33047168,-	p@chr18:33047157..33047168, -
1.58e-32	FFCP PHASE1:Hg19::chr18:33047157..33047168,-	p@chr18:33047157..33047168, -
6.55e-32	FFCP PHASE1:Hg19::chr7:139741594..139741615,-	p5@PARP12
6.55e-32	FFCP PHASE2:Hg19::chr7:139741594..139741615,-	p5@PARP12
9.29e-32	FFCP PHASE2:Hg19::chr4:145566874..145566889,+	p15@HHIP
9.29e-32	FFCP PHASE1:Hg19::chr4:145566874..145566889,+	p15@HHIP
1.88e-31	FFCP PHASE1:Hg19::chr12:118112251..118112272,-	p12@KSR2
1.88e-31	FFCP PHASE2:Hg19::chr12:118112251..118112272,-	p12@KSR2
2.75e-31	FFCP PHASE1:Hg19::chr3:43538305..43538325,-	p@chr3:43538305..43538325, -
2.75e-31	FFCP PHASE2:Hg19::chr3:43538305..43538325,-	p@chr3:43538305..43538325, -
6.38e-30	FFCP PHASE1:Hg19::chr10:50153703..50153720,+	p7@WDFY4
6.38e-30	FFCP PHASE2:Hg19::chr10:50153703..50153720,+	p7@WDFY4
1.0e-29	FFCP PHASE1:Hg19::chr2:36796813..36796868,-	p@chr2:36796813..36796868, -
1.0e-29	FFCP PHASE2:Hg19::chr2:36796813..36796868,-	p@chr2:36796813..36796868, -
1.02e-29	FFCP PHASE1:Hg19::chrX:71299684..71299699,+	p@chrX:71299684..71299699, +
1.02e-29	FFCP PHASE2:Hg19::chrX:71299684..71299699,+	p@chrX:71299684..71299699, +
3.22e-29	FFCP PHASE1:Hg19::chr10:50153735..50153750,+	p6@WDFY4
3.22e-29	FFCP PHASE2:Hg19::chr10:50153735..50153750,+	p6@WDFY4
8.8e-29	FFCP PHASE2:Hg19::chr12:7585997..7586021,-	p@chr12:7585997..7586021, -
8.8e-29	FFCP PHASE1:Hg19::chr12:7585997..7586021,-	p@chr12:7585997..7586021, -
4.75e-28	FFCP PHASE2:Hg19::chr12:52080755..52080778,+	p@chr12:52080755..52080778, +
4.75e-28	FFCP PHASE1:Hg19::chr12:52080755..52080778,+	p@chr12:52080755..52080778, +
5.89e-28	FFCP PHASE1:Hg19::chrX:15518894..15518905,+	p2@BMX
5.89e-28	FFCP PHASE2:Hg19::chrX:15518894..15518905,+	p2@BMX
8.93e-28	FFCP PHASE1:Hg19::chr3:58034268..58034295,+	p@chr3:58034268..58034295, +
8.93e-28	FFCP PHASE2:Hg19::chr3:58034268..58034295,+	p@chr3:58034268..58034295, +
1.03e-27	FFCP PHASE1:Hg19::chr14:75469820..75469826,+	p4@EIF2B2
1.03e-27	FFCP PHASE2:Hg19::chr14:75469820..75469826,+	p4@EIF2B2
1.63e-27	FFCP PHASE1:Hg19::chr7:150329732..150329739,-	p8@GIMAP6
1.63e-27	FFCP PHASE2:Hg19::chr7:150329732..150329739,-	p8@GIMAP6
1.67e-27	FFCP PHASE1:Hg19::chr6:3753188..3753192,-	p@chr6:3753188..3753192, -
1.67e-27	FFCP PHASE2:Hg19::chr6:3753188..3753192,-	p@chr6:3753188..3753192, -
1.74e-27	FFCP PHASE2:Hg19::chr12:12491541..12491552,-	p11@MANSC1
1.74e-27	FFCP PHASE1:Hg19::chr12:12491541..12491552,-	p11@MANSC1
1.82e-27	FFCP PHASE1:Hg19::chr6:148664333..148664338,-	p@chr6:148664333..148664338, -
1.82e-27	FFCP PHASE2:Hg19::chr6:148664333..148664338,-	p@chr6:148664333..148664338, -
2.66e-27	FFCP PHASE1:Hg19::chr10:99655692..99655725,-	p@chr10:99655692..99655725, -
2.66e-27	FFCP PHASE2:Hg19::chr10:99655692..99655725,-	p@chr10:99655692..99655725, -
3.22e-27	FFCP PHASE1:Hg19::chr1:6479968..6479986,-	p1@HES2
3.22e-27	FFCP PHASE2:Hg19::chr1:6479968..6479986,-	p1@HES2
4.93e-27	FFCP PHASE1:Hg19::chr5:95920642..95920681,+	p1@ENST00000513158
4.93e-27	FFCP PHASE2:Hg19::chr5:95920642..95920681,+	p1@ENST00000513158
5.58e-27	FFCP PHASE1:Hg19::chr15:83953373..83953386,-	p2@BNC1
5.58e-27	FFCP PHASE2:Hg19::chr15:83953373..83953386,-	p2@BNC1
5.61e-27	FFCP PHASE1:Hg19::chr9:139563124..139563129,+	p@chr9:139563124..139563129, +
5.61e-27	FFCP PHASE2:Hg19::chr9:139563124..139563129,+	p@chr9:139563124..139563129, +
8.05e-27	FFCP PHASE2:Hg19::chr12:80084018..80084035,-	p17@PAWR
8.05e-27	FFCP PHASE1:Hg19::chr12:80084018..80084035,-	p17@PAWR
1.95e-26	FFCP PHASE2:Hg19::chr19:38794797..38794810,+	p2@C19orf33
1.95e-26	FFCP PHASE1:Hg19::chr19:38794797..38794810,+	p2@C19orf33
2.17e-26	FFCP PHASE1:Hg19::chr6:78171746..78171769,+	p@chr6:78171746..78171769, +
2.17e-26	FFCP PHASE2:Hg19::chr6:78171746..78171769,+	p@chr6:78171746..78171769, +
3.65e-26	FFCP PHASE2:Hg19::chr7:150690812..150690817,+	p10@NOS3
3.65e-26	FFCP PHASE1:Hg19::chr7:150690812..150690817,+	p10@NOS3
4.74e-26	FFCP PHASE2:Hg19::chr5:176433333..176433349,-	p11@UIMC1
4.74e-26	FFCP PHASE1:Hg19::chr5:176433333..176433349,-	p11@UIMC1
8.11e-26	FFCP PHASE1:Hg19::chr2:237076069..237076110,+	p1@ENST00000415226, p1@ENST00000483218
8.11e-26	FFCP PHASE2:Hg19::chr2:237076069..237076110,+	p1@ENST00000415226, p1@ENST00000483218
8.2e-26	FFCP PHASE1:Hg19::chr5:34656634..34656645,+	p15@RAI14
8.2e-26	FFCP PHASE2:Hg19::chr5:34656634..34656645,+	p15@RAI14
1.05e-25	FFCP PHASE1:Hg19::chr4:79472785..79472796,+	p3@ANXA3
1.05e-25	FFCP PHASE2:Hg19::chr4:79472785..79472796,+	p3@ANXA3
1.3e-25	FFCP PHASE1:Hg19::chr14:38725228..38725236,-	p5@CLEC14A
1.3e-25	FFCP PHASE2:Hg19::chr14:38725228..38725236,-	p5@CLEC14A
1.81e-25	FFCP PHASE1:Hg19::chr13:34727644..34727660,-	p@chr13:34727644..34727660, -
1.81e-25	FFCP PHASE2:Hg19::chr13:34727644..34727660,-	p@chr13:34727644..34727660, -
1.89e-25	FFCP PHASE2:Hg19::chr14:59830398..59830424,+	p@chr14:59830398..59830424, +
1.89e-25	FFCP PHASE1:Hg19::chr14:59830398..59830424,+	p@chr14:59830398..59830424, +
3.02e-25	FFCP PHASE2:Hg19::chr17:62084108..62084111,-	p5@ICAM2
3.02e-25	FFCP PHASE1:Hg19::chr17:62084108..62084111,-	p5@ICAM2
3.33e-25	FFCP PHASE1:Hg19::chr1:22264210..22264241,+	p@chr1:22264210..22264241, +
3.33e-25	FFCP PHASE2:Hg19::chr1:22264210..22264241,+	p@chr1:22264210..22264241, +
4.29e-25	FFCP PHASE2:Hg19::chr6:11607864..11607875,+	p@chr6:11607864..11607875, +
4.29e-25	FFCP PHASE1:Hg19::chr6:11607864..11607875,+	p@chr6:11607864..11607875, +
5.52e-25	FFCP PHASE1:Hg19::chr11:124761247..124761258,-	p@chr11:124761247..124761258, -
5.52e-25	FFCP PHASE2:Hg19::chr11:124761247..124761258,-	p@chr11:124761247..124761258, -
6.31e-25	FFCP PHASE2:Hg19::chr12:105863705..105863718,+	p@chr12:105863705..105863718, +
6.31e-25	FFCP PHASE1:Hg19::chr12:105863705..105863718,+	p@chr12:105863705..105863718, +
1.14e-24	FFCP PHASE1:Hg19::chr14:38725249..38725254,-	p6@CLEC14A
1.14e-24	FFCP PHASE2:Hg19::chr14:38725249..38725254,-	p6@CLEC14A
1.17e-24	FFCP PHASE1:Hg19::chr9:139541134..139541139,+	p@chr9:139541134..139541139, +
1.17e-24	FFCP PHASE2:Hg19::chr9:139541134..139541139,+	p@chr9:139541134..139541139, +
1.26e-24	FFCP PHASE1:Hg19::chr4:85791667..85791699,-	p@chr4:85791667..85791699, -
1.26e-24	FFCP PHASE2:Hg19::chr4:85791667..85791699,-	p@chr4:85791667..85791699, -
1.58e-24	FFCP PHASE1:Hg19::chr3:148599249..148599271,+	p2@CPA3
1.58e-24	FFCP PHASE2:Hg19::chr3:148599249..148599271,+	p2@CPA3
2.44e-24	FFCP PHASE1:Hg19::chr9:139543445..139543462,+	p@chr9:139543445..139543462, +
2.44e-24	FFCP PHASE2:Hg19::chr9:139543445..139543462,+	p@chr9:139543445..139543462, +
3.04e-24	FFCP PHASE2:Hg19::chr12:96830523..96830532,+	p@chr12:96830523..96830532, +
3.04e-24	FFCP PHASE1:Hg19::chr12:96830523..96830532,+	p@chr12:96830523..96830532, +
4.4e-24	FFCP PHASE1:Hg19::chr20:50721803..50721857,-	p2@ZFP64
4.4e-24	FFCP PHASE2:Hg19::chr20:50721803..50721857,-	p2@ZFP64

Showing 1 to 100 of 100 entries